Aurobindo Pharma gets final USFDA nod for dementia drug

Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Rivastigmine Tartrate Capsules USP.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news